Biochemical, genomic, and epigenomic profiling of isolated cancer cell lines' micronuclei

Albert S Agustinus1, Samuel Bakhoum2

  • 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Department of Pharmacology, Weill Cornell Graduate School, New York, NY, United States.

Methods in Cell Biology
|September 5, 2022
PubMed

Insights

Researchers developed new methods to analyze micronuclei, which are byproducts of cancer cell division. These techniques profile the biochemical, genomic, and epigenomic properties of micronuclei, aiding cancer research.

Area of Science:

  • Cell Biology
  • Genetics
  • Cancer Research

Background:

  • Micronuclei are byproducts of cell division in chromosomally unstable cancer cells.
  • They play a critical role in cancer metastasis and the propagation of chromosomal abnormalities.
  • Understanding micronuclei is crucial for studying tumor initiation and progression.

Purpose of the Study:

  • To present methods for profiling the biochemical, genomic, and epigenomic properties of micronuclei.
  • To provide a versatile approach for investigating biological events within micronuclei.
  • To enable comparison of events in micronuclei versus primary nuclei.

Main Methods:

  • Physical isolation of micronuclei.
  • Induction of micronuclei formation using MPS1 inhibition or radiation.
  • Profiling of biochemical, genomic, and epigenomic characteristics.

Main Results:

  • Established methods to isolate and profile micronuclei.
  • Demonstrated a versatile system for studying micronuclear biological events.
  • Enabled comparative analysis between micronuclei and primary nuclei.

Conclusions:

  • The presented methods offer a powerful tool for in-depth analysis of micronuclei.
  • This approach facilitates a deeper understanding of micronuclei's role in cancer progression.
  • Further research can leverage these techniques to explore therapeutic strategies targeting micronuclei.